Literature DB >> 10658518

Rho-like GTPases: their role in epithelial cell-cell adhesion and invasion.

E E Sander1, J G Collard.   

Abstract

The family members of small Rho-like GTPases, RhoA, Rac1 and Cdc42Hs, are regulators of diverse cellular signalling pathways, including cytoskeletal organisation, transcription and cell-cycle progression. Recent research has given insight into the complex regulation of cell-cell adhesion and migratory responses of epithelial cells. The Rho-like GTPases RhoA, Rac1 and Cdc42Hs as major determinants of cytoskeletal organisation have been identified as key regulators of epithelial architecture, as well as of cell migration. These findings highlight the complex regulation and cross-talk of GTPase-dependent signalling pathways arising from cell-cell and cell-matrix interactions. The molecular mechanism of how Rho-like GTPases couple to molecules mediating either cell-cell adhesion or cell migration will be of particular interest to understand the invasive phenotype of epithelial tumours.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10658518     DOI: 10.1016/s0959-8049(99)00145-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells.

Authors:  Benjamin Chaigne-Delalande; Lynda Deuve; Edith Reuzeau; Caroline Basoni; David Lafarge; Christine Varon; Florence Tatin; Guerric Anies; Richard Garand; Ijsbrand Kramer; Elisabeth Génot
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 2.  Computational drug discovery.

Authors:  Si-Sheng Ou-Yang; Jun-Yan Lu; Xiang-Qian Kong; Zhong-Jie Liang; Cheng Luo; Hualiang Jiang
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

3.  Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.

Authors:  J Hutchinson; J Jin; R D Cardiff; J R Woodgett; W J Muller
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  The expression of rho proteins decreases with human brain tumor progression: potential tumor markers.

Authors:  Marie-Annick Forget; Richard R Desrosiers; MaestroRolandaF Del; Robert Moumdjian; Daniel Shedid; France Berthelet; Richard Béliveau
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 5.  Genetic basis of human breast cancer metastasis.

Authors:  M T Debies; D R Welch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

6.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

7.  Light-mediated activation reveals a key role for Rac in collective guidance of cell movement in vivo.

Authors:  Xiaobo Wang; Li He; Yi I Wu; Klaus M Hahn; Denise J Montell
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

8.  The Rac activator Tiam1 is required for (alpha)3(beta)1-mediated laminin-5 deposition, cell spreading, and cell migration.

Authors:  Irene H L Hamelers; Cristina Olivo; Alexander E E Mertens; D Michiel Pegtel; Rob A van der Kammen; Arnoud Sonnenberg; John G Collard
Journal:  J Cell Biol       Date:  2005-12-05       Impact factor: 10.539

9.  EspT triggers formation of lamellipodia and membrane ruffles through activation of Rac-1 and Cdc42.

Authors:  Richard R Bulgin; Ana Arbeloa; Jade C S Chung; Gad Frankel
Journal:  Cell Microbiol       Date:  2008-10-30       Impact factor: 3.715

10.  PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells.

Authors:  Jean-Pierre Couty; Christine Rampon; Mathilde Leveque; Marie-Pierre Laran-Chich; Sandrine Bourdoulous; John Greenwood; Pierre-Olivier Couraud
Journal:  J Neurochem       Date:  2007-07-27       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.